ResourcesVendorsPathology & AISiemens Healthineers40 Liberty Boulevard Malvern, PA, USA 19355Latest from Siemens HealthineersFunding and FinanceSiemens Healthineers to close Fast Track Diagnostics unitBy LabPulse.com staff writersSiemens Healthineers intends to close its Fast Track Diagnostics unit by September 2024.March 19, 2024SepsisSiemens Healthineers contracts with NIAID to develop NGS-based sepsis testBy LabPulse.com staff writersSiemens Healthineers has secured a three-year, $5.5 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health, to develop a test to improve sepsis treatment.November 22, 2023Funding and FinanceSiemens Healthineers to implement layoffs at NJ facilityBy LabPulse.com staff writersTo consolidate the manufacturing of its Atellica Solution platform at its Dublin facility, Siemens will lay off the workforce involved in the production of the platform at its Flanders, NJ, manufacturing facility.November 6, 2023ImmunoassaysSiemens Healthineers adds compact testing system to its IVD portfolioBy LabPulse.com staff writersThe Atellica CI analyzer has a 1.9 square meter footprint, making it ideal for smaller laboratories, but uses the same reagents, consumables, and Atellica Laboratory Evaluation Suite software as the company's Atellica Solution.July 20, 2023Compliance and RegulationWeek in Review: Quest on detecting dementia | Roche routine mass-spec test | A Labcorp acquisitionBy Leo O'ConnorRoche Diagnostics will showcase technologies for lab automation, the serum work area, and molecular and point-of-care solutions at an industry event; it is also unveiling a prototype for the Cobas Mass Spec system.May 18, 2023Product LaunchSiemens Healthineers to unveil next-gen hematology analyzers at EuroMedLab 2023By LabPulse.com staff writersThe firm said its hematology analyzers leverage advanced data management to mitigate the current lab expertise gap, enabling staff of any skill level to interpret results.May 16, 2023Financial ResultsSiemens Healthineers Q2 diagnostics revenues drop 39% on decline in rapid antigen test salesBy Leo O'ConnorThe firm is seeing a return to low- to mid-single digital revenue growth as swings in demand from COVID-19 testing to routine testing normalize, Sharon Bracken, its president of diagnostics, said in an interview.May 10, 2023AgreementSiemens Healthineers to distribute Scopio Labs’ full-field digital cell morphology technologyBy LabPulse.com staff writersSiemens Healthineers said the Scopio X100 and Scopio X100HT imaging platforms will complement its IVD systems, including the Atellica Hema 570 and Atellica Hema 580 analyzers.May 8, 2023Compliance and RegulationMexico IVD sales reach $794M: Kalorama InformationBy Daniel GrandersonImmunoassays are Mexico’s leading IVD segment, followed by point-of-care and microbiology/molecular. Other POC, other molecular, and flow cytometry will be key segments to watch in coming years.April 11, 2023Compliance and RegulationWeek in Review: QuidelOrtho de novo authorization | Veracyte growth plans | Abbott concussion test clearanceBy Leo O'ConnorThe FDA granted clearance to Abbott for the first commercially available laboratory test to detect concussion and a de novo request allowing QuidelOrtho to market its Sofia 2 SARS Antigen+ FIA test for use by prescription only.March 9, 2023Pathology, histologyHamamatsu, Siemens Healthineers sign distribution agreement for whole-slide scannersBy LabPulse.com staff writersHamamatsu will provide its NanoZoomer whole-slide scanners to support Siemens Healthineers’ expansion into digital pathology in the Americas and Europe.March 8, 2023CollaborationSiemens Healthineers, Unilabs ink 200-million euro agreementBy LabPulse.com staff writersIn the first years of the agreement, Siemens Healthineers will install high- and mid-volume immunoassay and clinical chemistry analyzers, including the Atellica Solution and Atellica CI 1900, sample handlers, hemostasis analyzers, and automation solutionFebruary 2, 2023Compliance and RegulationWeek in Review: VALID Act out; Alzheimer's blood marker; OTC test EUAs; made-in-America contract; moreBy Leo O'ConnorSiemens Healthineers faced challenges this year that were reflective of industry-wide constraints. They included elevated procurement and logistics costs, logistical constraints and shortages, and lower revenues due to less demand for COVID testing.December 29, 2022Compliance and RegulationWeek in Review: Study confirms long COVID as public health threat; test-and-treat disparities; multianalyte respiratory testing; moreBy Leo O'ConnorWeek in Review: Study confirms long COVID as public health threat; test-and-treat disparities; multianalyte respiratory testing; moreNovember 10, 2022Financial ResultsSiemens Healthineers Q4 Dx revenues rise 13% on increased sales of COVID-19 rapid antigen testsBy Leo O'ConnorIn the recently completed quarter, Siemens Healthineers booked €232 million from COVID-19 rapid antigen tests compared to around €160 million in Q4 2021.November 9, 2022
